Health tech companies are seeing significant investment and continued innovation, with recent funding rounds and advancements in artificial intelligence shaping the future of patient care. Talkiatry, a mental health provider, secured $210 million in funding to expand its use of AI in patient engagement, even as Big Health received funding as investors express optimism about digital therapeutics.
The investment in Talkiatry highlights a growing trend of utilizing AI to improve access to and the quality of mental healthcare. The company intends to leverage the funding to enhance its platform and broaden its reach, addressing a critical require for accessible mental health services. According to reporting, Talkiatry’s approach focuses on using AI to personalize patient interactions and improve treatment outcomes.
Big Health’s funding round signals increasing investor confidence in the potential of digital therapeutics. These programs, delivered through software and apps, aim to treat medical conditions and improve patient health. The funding will likely support further development and clinical validation of Big Health’s digital therapeutic offerings.
Alongside investment, research continues into the accuracy of health-focused features on consumer devices. A recent study is re-examining Apple’s hypertension feature, assessing its ability to accurately detect and monitor high blood pressure. The feature, designed to provide users with insights into their cardiovascular health, is under scrutiny to ensure its reliability and clinical validity.
Further innovation is occurring in the realm of AI-powered clinical documentation. Abridge, a company focused on AI scribing, is exploring integrations with Epic, a leading electronic health record system. The company’s CTO discussed the future of AI in healthcare, moving beyond simple transcription to more sophisticated clinical insights and decision support.
